These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17536345)

  • 1. Prostate cancer in a man with multiple previous cancers.
    Flaig T; Crawford ED; Kavanagh B; Lucia S; La Rosa F; Barqawi A; Crighton F; Glodé LM
    Oncology (Williston Park); 2007 Apr; 21(5):611-4. PubMed ID: 17536345
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
    Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
    Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic cancer in a young adult: a report of 2 cases].
    Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma.
    Huang E; Teh BS; Saleem A; Butler EB
    Urology; 2002 Dec; 60(6):1111. PubMed ID: 12475684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving role of familial history for prostate cancer.
    Colloca G; Venturino A
    Acta Oncol; 2011 Jan; 50(1):14-24. PubMed ID: 20874046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer.
    McCleod S
    Aviat Space Environ Med; 2006 Sep; 77(9):984-6. PubMed ID: 16964751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does baseline total testosterone improve the yielding of prostate cancer screening?
    Botelho F; Pina F; Figueiredo L; Cruz F; Lunet N
    Eur J Cancer; 2012 Jul; 48(11):1657-63. PubMed ID: 22342552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate carcinoma with peripheral metastases after prostatectomy and low levels of serum prostate specific antigen.
    Seven B; Varoglu E; Cayir K; Sahin A; Kantarci M
    Hell J Nucl Med; 2008; 11(1):53-4. PubMed ID: 18392233
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic cancer.
    Olsson C
    Kidney Int; 1993 Apr; 43(4):955-65. PubMed ID: 7683069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostate, cancer and lost patients].
    Nau JY
    Rev Med Suisse; 2012 May; 8(343):1186-7. PubMed ID: 22737953
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
    Mystakidou K; Katsouda E; Parpa E; Vlahos L
    J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
    Choueiri TK; Dreicer R; Paciorek A; Carroll PR; Konety B
    J Urol; 2008 Mar; 179(3):906-10; discussion 910. PubMed ID: 18207194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of primary transitional cell carcinoma of the prostate].
    Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
    Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) immunohistochemistry in the presence of a normal serum PSA as an aid to diagnosis of adenocarcinoma of unknown primary site.
    Harper CL; Lofts FJ; Otter M; Mansi JL
    Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):367-8. PubMed ID: 8696637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
    Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
    Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: a chronic illness.
    Doyle-Lindrud S
    Clin J Oncol Nurs; 2007 Dec; 11(6):857-61. PubMed ID: 18063544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.